ZNF503 and neoplasm: Patients with low ZNF503-AS2 expression had a better prognosis when the degree of tumor-associated macrophages (TAMs) infiltration was high, suggesting that ZNF503-AS2 may serve as a valid target for patients with high macrophage infiltration.